Translational Neurodegeneration

SJR Rank #287H-index: 77SJR: 4.992Best quartile: Q1Open AccessAPC: US$2,990Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • Cellular and Molecular NeuroscienceQ1
  • Cognitive NeuroscienceQ1
  • Neurology (clinical)Q1

Areas: Medicine · Neuroscience

Most published research topics

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeurological disorders and treatmentsAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment ResearchGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurogenesis and neuroplasticity mechanismsNeurological diseases and metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

20222025020406080

Detailed Information

ISSN

2047-9158

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

15.12

References per Document

128.21

Coverage

2012-2026

Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Metrics from SCImago Journal Rank 2025. View on SCImago